Tolerability, safety and pharmacokinetics of ridaforolimus in combination with bicalutamide in patients with asymptomatic, metastatic castration-resistant prostate cancer (CRPC)

Author： Meulenbeld Hielke   Bono Johann   Tagawa Scott   Whang Young   Li Xiaoyun   Heath Karl   Zandvliet Anthe   Ebbinghaus Scot   Hudes Gary   Wit Ronald  

Publisher： Springer Publishing Company

ISSN： 0344-5704

Source： Cancer Chemotherapy and Pharmacology, Vol.72, Iss.4, 2013-10, pp. : 909-916

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Effect of abiraterone acetate plus prednisone on the pharmacokinetics of dextromethorphan and theophylline in patients with metastatic castration-resistant prostate cancer

By Chi K.   Tolcher A.   Lee P.   Rosen P.   Kollmannsberger C.   Papadopoulos K.   Patnaik A.   Molina A.   Jiao J.   Pankras C.   Kaiser B.   Bernard A.   Tran N.   Acharya M.  

Cancer Chemotherapy and Pharmacology, Vol. 71, Iss. 1, 2013-01 ,pp. : 237-244

Springer Publishing Company

Access to resources Recommend Favorite

A combination trial of vaccine plus ipilimumab in metastatic castration-resistant prostate cancer patients: immune correlates

By Jochems Caroline   Tucker Jo   Tsang Kwong-Yok   Madan Ravi   Dahut William   Liewehr David   Steinberg Seth   Gulley James   Schlom Jeffrey  

Cancer Immunology, Immunotherapy, Vol. 63, Iss. 4, 2014-04 ,pp. : 407-418

Springer Publishing Company

Access to resources Recommend Favorite

Carboplatin-etoposide combination chemotherapy in metastatic castration-resistant prostate cancer: A retrospective study

By                      

Molecular and Clinical Oncology, Vol. 3, Iss. 6, 2015-01 ,pp. : 1208-1212

Science Publishers

Access to resources Recommend Favorite

Effect of abiraterone acetate on fatigue in patients with metastatic castration-resistant prostate cancer after docetaxel chemotherapy

By Sternberg C. N.   Molina A.   North S.   Mainwaring P.   Fizazi K.   Hao Y.   Rothman M.   Gagnon D. D.   Kheoh T.   Haqq C. M.   Cleeland C.   de Bono J. S.   Scher H. I.  

Annals of Oncology, Vol. 24, Iss. 4, 2013-04 ,pp. : 1017-1025

Oxford University Press

Access to resources Recommend Favorite

Serum sarcosine is a risk factor for progression and survival in patients with metastatic castration-resistant prostate cancer

By Lucarelli Giuseppe   Ditonno Pasquale   Bettocchi Carlo   Spilotros Marco   Rutigliano Monica   Vavallo Antonio   Galleggiante Vanessa   Fanelli Margherita   Larocca Angela Maria Vittoria   Germinario Cinzia Annatea   Maiorano Eugenio   Selvaggi Francesco Paolo   Battaglia Michele  

Future Oncology, Vol. 9, Iss. 6, 2013-06 ,pp. : 899-907

Future Medicine

Access to resources Recommend Favorite